LIVN Live signals | Maximize Profits with Getagraph.com

SELL 89224 min ago

@ $49.09

Issued: 14 Feb 2024 @ 09:30

Return: 9.06%

Previous signal: Feb 9 - 15:40

Previous signal: Buy

Return: -2.06 %

Live Chart Being Loaded With Signals

Commentary (16 Apr 2024 @ 09:32):

Stats
Today's Volume	4 036.00
Average Volume	646 580
Market Cap	2.89B
EPS	$0 ( 2024-02-21 )
Next earnings date	( $0.450 ) 2024-05-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	167.31
ATR14	$0.0400 (0.07%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-30	Bolton Stephanie	Buy	7 744	Ordinary Shares
2024-03-30	Bolton Stephanie	Buy	10 746	Stock Appreciation Rights
2024-03-30	Bolton Stephanie	Sell	3 643	Ordinary Shares
2024-03-30	Bolton Stephanie	Buy	4 915	Restricted Stock Units
2024-03-30	Bolton Stephanie	Buy	4 915	Performance Stock Units

INSIDER POWER
50.87
Last 100 transactions
Buy: 371 593 \| Sell: 126 373

Volume Correlation

Long: 0.56 (weak)

Short: 0.23 (neutral)

Signal:(60.125) Neutral

LivaNova PLC Correlation

10 Most Positive Correlations
IMPL	0.932
AFYA	0.931
JFU	0.928
INVA	0.925
EAR	0.923
AVIR	0.923
TUEM	0.922
DTSS	0.92
AZTA	0.91
IMV	0.91

10 Most Negative Correlations
SERA	-0.945
NEO	-0.938
XLRN	-0.93
TA	-0.93
MLTX	-0.922
NTRA	-0.92
ZGNX	-0.91
XPON	-0.909
CPTA	-0.908
PAE	-0.908

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

LivaNova PLC Correlation - Currency/Commodity

-0.37
( neutral )

-0.38
( neutral )

0.00
( neutral )

-0.61
( weak negative )

-0.66
( moderate negative )

0.55
( weak )

LivaNova PLC Financials

Annual	2023
Revenue:	$1.15B
Gross Profit:	$785.45M (68.09 %)
EPS:	$0.330

Q4	2023
Revenue:	$310.10M
Gross Profit:	$190.20M (61.34 %)
EPS:	$0.300

Q3	2023
Revenue:	$286.10M
Gross Profit:	$201.80M (70.53 %)
EPS:	$-0.140

Q2	2023
Revenue:	$293.90M
Gross Profit:	$205.20M (69.82 %)
EPS:	$0.0215

Financial Reports:

No articles found.

LivaNova PLC

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.